CD69 and COVID-19: ,49 This model allows precise temporal tracking of immune cell infiltration in the lung, a compartment directly comparable to the BALF analyzed in COVID-19 patients, thereby providing an in vivo system to test whether ALARM-associated markers such as CXCR4 and CD69 are similarly induced during acute pulmonary infection.